Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children

被引：0
|
作者：
Joseph R DiFranza
Anthony Masaquel
Amy M Barrett
Ann D Colosia
Parthiv J Mahadevia
机构：
[1] University of Massachusetts Medical School,Department of Family Medicine and Community Health
[2] One MedImmune Way,MedImmune, Health Outcomes & Pharmacoeconomics
[3] RTI Health Solutions,undefined
来源：
BMC Pediatrics | / 12卷
关键词：
Respiratory syncytial virus; Respiratory infection; Tobacco; Smoking; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants - A systematic review
    Kamal-Bahl, S
    Doshi, J
    Campbell, J
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (10): : 1034 - 1041
  • [22] Respiratory syncytial virus reinfections among infants and young children in the United States, 2011-2019
    Nduaguba, Sabina O.
    Tran, Phuong T.
    Choi, Yoonyoung
    Winterstein, Almut G.
    PLOS ONE, 2023, 18 (02):
  • [23] Strategies for Reducing the Risk of Respiratory Syncytial Virus Infection in Infants and Young Children: A Canadian Nurses' Perspective
    Bracht, Marianne
    Basevitz, Debbie
    Cranis, Marilyn
    Paulley, Rose
    Paes, Bosco
    NEONATAL NETWORK, 2012, 31 (06): : 357 - 368
  • [24] Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children
    Fly, J. Hunter
    Eiland, Lea S.
    Stultz, Jeremy S.
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [25] Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
    Wang, D.
    Bayliss, S.
    Meads, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (05) : 1 - +
  • [26] Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: A systematic literature review and meta-analysis
    Checchia, Paul A.
    Nalysnyk, Luba
    Fernandes, Ancilla W.
    Mahadevia, Parthiv J.
    Xu, Yingxin
    Fahrbach, Kyle
    Welliver, Robert C., Sr.
    PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (05) : 580 - 588
  • [27] Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
    Movva, Naimisha
    Suh, Mina
    Bylsma, Lauren C.
    Fryzek, Jon P.
    Nelson, Christopher B.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2): : S213 - S224
  • [28] Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants
    Staebler, Suzanne
    Blake, Stephanie
    POLICY POLITICS & NURSING PRACTICE, 2021, 22 (01) : 41 - 50
  • [29] Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in Young Children
    Papenburg, Jesse
    Hamelin, Marie-Eve
    Ouhoummane, Najwa
    Carbonneau, Julie
    Ouakki, Manale
    Raymond, Frederic
    Robitaille, Lynda
    Corbeil, Jacques
    Caouette, Georges
    Frenette, Lyne
    De Serres, Gaston
    Boivin, Guy
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (02): : 178 - 189
  • [30] PROPHYLACTIC ADMINISTRATION OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN TO HIGH-RISK INFANTS AND YOUNG-CHILDREN
    GROOTHUIS, JR
    SIMOES, EAF
    LEVIN, MJ
    HALL, CB
    LONG, CE
    RODRIGUEZ, WJ
    ARROBIO, J
    MEISSNER, HC
    FULTON, DR
    WELLIVER, RC
    TRISTRAM, DA
    SIBER, GR
    PRINCE, GA
    VANRADEN, M
    HEMMING, VG
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21): : 1524 - 1530
12345